context
stringlengths 21
24.6k
| category
stringclasses 2
values | entity
stringlengths 1
12
| entity_type
stringclasses 5
values | query
stringlengths 97
3.31k
| answer
stringlengths 12
168
|
|---|---|---|---|---|---|
Advertising costs are expensed as incurred and totaled $ 1,286,000 in 2024, $ 1,190,000 in 2023, and $ 1,257,000 in 2022. | text | 1190000 | monetaryItemType | text: <entity> 1190000 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and totaled $ 1,286,000 in 2024, $ 1,190,000 in 2023, and $ 1,257,000 in 2022. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred and totaled $ 1,286,000 in 2024, $ 1,190,000 in 2023, and $ 1,257,000 in 2022. | text | 1257000 | monetaryItemType | text: <entity> 1257000 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and totaled $ 1,286,000 in 2024, $ 1,190,000 in 2023, and $ 1,257,000 in 2022. </context> | us-gaap:AdvertisingExpense |
Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. Accumulated other comprehensive loss, net of tax, consists of foreign currency translation adjustment losses of $ 67,808,000 and $ 36,550,000 , as of December 31, 2024 and December 31, 2023, respectively; net unrealized losses on available-for-sale investments of $ 3,698,000 and $ 7,515,000 as of December 31, 2024 and December 31, 2023, respectively; and losses on currency swaps, net of gains on long-term intercompany loans of $ 1,271,000 at each year end. | text | 67808000 | monetaryItemType | text: <entity> 67808000 </entity> <entity type> monetaryItemType </entity type> <context> Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. Accumulated other comprehensive loss, net of tax, consists of foreign currency translation adjustment losses of $ 67,808,000 and $ 36,550,000 , as of December 31, 2024 and December 31, 2023, respectively; net unrealized losses on available-for-sale investments of $ 3,698,000 and $ 7,515,000 as of December 31, 2024 and December 31, 2023, respectively; and losses on currency swaps, net of gains on long-term intercompany loans of $ 1,271,000 at each year end. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax |
Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. Accumulated other comprehensive loss, net of tax, consists of foreign currency translation adjustment losses of $ 67,808,000 and $ 36,550,000 , as of December 31, 2024 and December 31, 2023, respectively; net unrealized losses on available-for-sale investments of $ 3,698,000 and $ 7,515,000 as of December 31, 2024 and December 31, 2023, respectively; and losses on currency swaps, net of gains on long-term intercompany loans of $ 1,271,000 at each year end. | text | 36550000 | monetaryItemType | text: <entity> 36550000 </entity> <entity type> monetaryItemType </entity type> <context> Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. Accumulated other comprehensive loss, net of tax, consists of foreign currency translation adjustment losses of $ 67,808,000 and $ 36,550,000 , as of December 31, 2024 and December 31, 2023, respectively; net unrealized losses on available-for-sale investments of $ 3,698,000 and $ 7,515,000 as of December 31, 2024 and December 31, 2023, respectively; and losses on currency swaps, net of gains on long-term intercompany loans of $ 1,271,000 at each year end. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax |
Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. Accumulated other comprehensive loss, net of tax, consists of foreign currency translation adjustment losses of $ 67,808,000 and $ 36,550,000 , as of December 31, 2024 and December 31, 2023, respectively; net unrealized losses on available-for-sale investments of $ 3,698,000 and $ 7,515,000 as of December 31, 2024 and December 31, 2023, respectively; and losses on currency swaps, net of gains on long-term intercompany loans of $ 1,271,000 at each year end. | text | 3698000 | monetaryItemType | text: <entity> 3698000 </entity> <entity type> monetaryItemType </entity type> <context> Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. Accumulated other comprehensive loss, net of tax, consists of foreign currency translation adjustment losses of $ 67,808,000 and $ 36,550,000 , as of December 31, 2024 and December 31, 2023, respectively; net unrealized losses on available-for-sale investments of $ 3,698,000 and $ 7,515,000 as of December 31, 2024 and December 31, 2023, respectively; and losses on currency swaps, net of gains on long-term intercompany loans of $ 1,271,000 at each year end. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax |
Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. Accumulated other comprehensive loss, net of tax, consists of foreign currency translation adjustment losses of $ 67,808,000 and $ 36,550,000 , as of December 31, 2024 and December 31, 2023, respectively; net unrealized losses on available-for-sale investments of $ 3,698,000 and $ 7,515,000 as of December 31, 2024 and December 31, 2023, respectively; and losses on currency swaps, net of gains on long-term intercompany loans of $ 1,271,000 at each year end. | text | 7515000 | monetaryItemType | text: <entity> 7515000 </entity> <entity type> monetaryItemType </entity type> <context> Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. Accumulated other comprehensive loss, net of tax, consists of foreign currency translation adjustment losses of $ 67,808,000 and $ 36,550,000 , as of December 31, 2024 and December 31, 2023, respectively; net unrealized losses on available-for-sale investments of $ 3,698,000 and $ 7,515,000 as of December 31, 2024 and December 31, 2023, respectively; and losses on currency swaps, net of gains on long-term intercompany loans of $ 1,271,000 at each year end. </context> | us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax |
Accrued interest receivable is included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 4,144,000 and $ 3,169,000 as of December 31, 2024 and 2023, respectively. | text | 4144000 | monetaryItemType | text: <entity> 4144000 </entity> <entity type> monetaryItemType </entity type> <context> Accrued interest receivable is included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 4,144,000 and $ 3,169,000 as of December 31, 2024 and 2023, respectively. </context> | us-gaap:InterestReceivable |
Accrued interest receivable is included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 4,144,000 and $ 3,169,000 as of December 31, 2024 and 2023, respectively. | text | 3169000 | monetaryItemType | text: <entity> 3169000 </entity> <entity type> monetaryItemType </entity type> <context> Accrued interest receivable is included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 4,144,000 and $ 3,169,000 as of December 31, 2024 and 2023, respectively. </context> | us-gaap:InterestReceivable |
The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . | text | 9580000 | monetaryItemType | text: <entity> 9580000 </entity> <entity type> monetaryItemType </entity type> <context> The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . </context> | us-gaap:PropertyPlantAndEquipmentDisposals |
The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . | text | 9492000 | monetaryItemType | text: <entity> 9492000 </entity> <entity type> monetaryItemType </entity type> <context> The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . </context> | us-gaap:AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 |
The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . | text | 88000 | monetaryItemType | text: <entity> 88000 </entity> <entity type> monetaryItemType </entity type> <context> The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . </context> | us-gaap:GainLossOnDispositionOfAssets1 |
The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . | text | 12421000 | monetaryItemType | text: <entity> 12421000 </entity> <entity type> monetaryItemType </entity type> <context> The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . </context> | us-gaap:PropertyPlantAndEquipmentDisposals |
The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . | text | 12184000 | monetaryItemType | text: <entity> 12184000 </entity> <entity type> monetaryItemType </entity type> <context> The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . </context> | us-gaap:AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 |
The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . | text | 8000 | monetaryItemType | text: <entity> 8000 </entity> <entity type> monetaryItemType </entity type> <context> The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . </context> | us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment |
The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . | text | 229000 | monetaryItemType | text: <entity> 229000 </entity> <entity type> monetaryItemType </entity type> <context> The Company disposed of property, plant, and equipment with a cost basis of $ 9,580,000 and accumulated depreciation of $ 9,492,000 in 2024, resulting in a loss of $ 88,000 . The Company disposed of property, plant, and equipment with a cost basis of $ 12,421,000 and accumulated depreciation of $ 12,184,000 in 2023, net of proceeds of $ 8,000 , resulting in a loss of $ 229,000 . </context> | us-gaap:GainLossOnDispositionOfAssets1 |
The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. | text | 14131000 | monetaryItemType | text: <entity> 14131000 </entity> <entity type> monetaryItemType </entity type> <context> The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. </context> | us-gaap:OperatingLeaseExpense |
The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. | text | 11598000 | monetaryItemType | text: <entity> 11598000 </entity> <entity type> monetaryItemType </entity type> <context> The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. </context> | us-gaap:OperatingLeaseExpense |
The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. | text | 8939000 | monetaryItemType | text: <entity> 8939000 </entity> <entity type> monetaryItemType </entity type> <context> The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. </context> | us-gaap:OperatingLeaseExpense |
The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. | text | 13683000 | monetaryItemType | text: <entity> 13683000 </entity> <entity type> monetaryItemType </entity type> <context> The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. </context> | us-gaap:OperatingLeasePayments |
The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. | text | 10148000 | monetaryItemType | text: <entity> 10148000 </entity> <entity type> monetaryItemType </entity type> <context> The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. </context> | us-gaap:OperatingLeasePayments |
The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. | text | 8548000 | monetaryItemType | text: <entity> 8548000 </entity> <entity type> monetaryItemType </entity type> <context> The total operating lease expense was $ 14,131,000 in 2024, $ 11,598,000 in 2023, and $ 8,939,000 in 2022. The total operating lease cash payments were $ 13,683,000 in 2024, $ 10,148,000 in 2023, and $ 8,548,000 in 2022. The total lease expense for leases with a term of twelve months or less for which the Company elected not to recognize a lease asset or lease liability was $ 407,000 in 2024, $ 427,000 in 2023, and $ 144,000 in 2022. </context> | us-gaap:OperatingLeasePayments |
The discounted present value of the future lease cash payments resulted in a lease liability of $ 70,217,000 and $ 78,601,000 as of December 31, 2024 and 2023, respectively. | text | 78601000 | monetaryItemType | text: <entity> 78601000 </entity> <entity type> monetaryItemType </entity type> <context> The discounted present value of the future lease cash payments resulted in a lease liability of $ 70,217,000 and $ 78,601,000 as of December 31, 2024 and 2023, respectively. </context> | us-gaap:OperatingLeaseLiability |
The Company leases a building in Singapore that serves as a distribution center for customers in Asia. The lease contains two components: an 88,000 square-foot premises that had a commencement date in June of 2023 and a second 27,000 square-foot premises that does not commence until the fourth quarter of 2025. Accordingly, the second component of the lease has not yet been recorded on the Consolidated Balance Sheets, nor has it created any significant rights and obligations as of December 31, 2024. This second lease component has an original term of eight years and the Company has the right and option to extend this term by an additional five years, commencing upon the expiration of the original term. Future payment obligations associated with this lease component total $ 13,145,000 , $ 160,000 of which is payable in 2025 and which reflects an estimated extension period of five years . Future payment obligations related to this lease component are not included in the future operating lease cash payments table above. | text | 13145000 | monetaryItemType | text: <entity> 13145000 </entity> <entity type> monetaryItemType </entity type> <context> The Company leases a building in Singapore that serves as a distribution center for customers in Asia. The lease contains two components: an 88,000 square-foot premises that had a commencement date in June of 2023 and a second 27,000 square-foot premises that does not commence until the fourth quarter of 2025. Accordingly, the second component of the lease has not yet been recorded on the Consolidated Balance Sheets, nor has it created any significant rights and obligations as of December 31, 2024. This second lease component has an original term of eight years and the Company has the right and option to extend this term by an additional five years, commencing upon the expiration of the original term. Future payment obligations associated with this lease component total $ 13,145,000 , $ 160,000 of which is payable in 2025 and which reflects an estimated extension period of five years . Future payment obligations related to this lease component are not included in the future operating lease cash payments table above. </context> | us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue |
The Company leases a building in Singapore that serves as a distribution center for customers in Asia. The lease contains two components: an 88,000 square-foot premises that had a commencement date in June of 2023 and a second 27,000 square-foot premises that does not commence until the fourth quarter of 2025. Accordingly, the second component of the lease has not yet been recorded on the Consolidated Balance Sheets, nor has it created any significant rights and obligations as of December 31, 2024. This second lease component has an original term of eight years and the Company has the right and option to extend this term by an additional five years, commencing upon the expiration of the original term. Future payment obligations associated with this lease component total $ 13,145,000 , $ 160,000 of which is payable in 2025 and which reflects an estimated extension period of five years . Future payment obligations related to this lease component are not included in the future operating lease cash payments table above. | text | 160000 | monetaryItemType | text: <entity> 160000 </entity> <entity type> monetaryItemType </entity type> <context> The Company leases a building in Singapore that serves as a distribution center for customers in Asia. The lease contains two components: an 88,000 square-foot premises that had a commencement date in June of 2023 and a second 27,000 square-foot premises that does not commence until the fourth quarter of 2025. Accordingly, the second component of the lease has not yet been recorded on the Consolidated Balance Sheets, nor has it created any significant rights and obligations as of December 31, 2024. This second lease component has an original term of eight years and the Company has the right and option to extend this term by an additional five years, commencing upon the expiration of the original term. Future payment obligations associated with this lease component total $ 13,145,000 , $ 160,000 of which is payable in 2025 and which reflects an estimated extension period of five years . Future payment obligations related to this lease component are not included in the future operating lease cash payments table above. </context> | us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths |
The Company has entered into a lease for a 6,500 square-foot building in Aachen, Germany for a term of ten years . The commencement date for this lease is expected to be in the second quarter of 2025, and therefore it has not yet been recorded on the Consolidated Balance Sheets, nor has it created any significant rights and obligations as of December 31, 2024. The Company has the right and option to extend the term of this lease for an additional period of five years , commencing upon the expiration of the original term. Future payment obligations associated with this lease total $ 8,763,000 , $ 483,000 of which is payable in 2025. Future payment obligations related to this lease are not included in the future operating lease cash payments table above. | text | 8763000 | monetaryItemType | text: <entity> 8763000 </entity> <entity type> monetaryItemType </entity type> <context> The Company has entered into a lease for a 6,500 square-foot building in Aachen, Germany for a term of ten years . The commencement date for this lease is expected to be in the second quarter of 2025, and therefore it has not yet been recorded on the Consolidated Balance Sheets, nor has it created any significant rights and obligations as of December 31, 2024. The Company has the right and option to extend the term of this lease for an additional period of five years , commencing upon the expiration of the original term. Future payment obligations associated with this lease total $ 8,763,000 , $ 483,000 of which is payable in 2025. Future payment obligations related to this lease are not included in the future operating lease cash payments table above. </context> | us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount |
The Company has entered into a lease for a 6,500 square-foot building in Aachen, Germany for a term of ten years . The commencement date for this lease is expected to be in the second quarter of 2025, and therefore it has not yet been recorded on the Consolidated Balance Sheets, nor has it created any significant rights and obligations as of December 31, 2024. The Company has the right and option to extend the term of this lease for an additional period of five years , commencing upon the expiration of the original term. Future payment obligations associated with this lease total $ 8,763,000 , $ 483,000 of which is payable in 2025. Future payment obligations related to this lease are not included in the future operating lease cash payments table above. | text | 483000 | monetaryItemType | text: <entity> 483000 </entity> <entity type> monetaryItemType </entity type> <context> The Company has entered into a lease for a 6,500 square-foot building in Aachen, Germany for a term of ten years . The commencement date for this lease is expected to be in the second quarter of 2025, and therefore it has not yet been recorded on the Consolidated Balance Sheets, nor has it created any significant rights and obligations as of December 31, 2024. The Company has the right and option to extend the term of this lease for an additional period of five years , commencing upon the expiration of the original term. Future payment obligations associated with this lease total $ 8,763,000 , $ 483,000 of which is payable in 2025. Future payment obligations related to this lease are not included in the future operating lease cash payments table above. </context> | us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary |
The weighted-average discount rate was 5.9 % and 5.7 % for the leases outstanding as of December 31, 2024 and December 31, 2023, respectively. The weighted-average remaining lease term was 9.9 years and 10.5 years for the leases outstanding as of December 31, 2024 and 2023, respectively. | text | 5.9 | percentItemType | text: <entity> 5.9 </entity> <entity type> percentItemType </entity type> <context> The weighted-average discount rate was 5.9 % and 5.7 % for the leases outstanding as of December 31, 2024 and December 31, 2023, respectively. The weighted-average remaining lease term was 9.9 years and 10.5 years for the leases outstanding as of December 31, 2024 and 2023, respectively. </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
The weighted-average discount rate was 5.9 % and 5.7 % for the leases outstanding as of December 31, 2024 and December 31, 2023, respectively. The weighted-average remaining lease term was 9.9 years and 10.5 years for the leases outstanding as of December 31, 2024 and 2023, respectively. | text | 5.7 | percentItemType | text: <entity> 5.7 </entity> <entity type> percentItemType </entity type> <context> The weighted-average discount rate was 5.9 % and 5.7 % for the leases outstanding as of December 31, 2024 and December 31, 2023, respectively. The weighted-average remaining lease term was 9.9 years and 10.5 years for the leases outstanding as of December 31, 2024 and 2023, respectively. </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
As of December 31, 2024, the Company had outstanding purchase orders totaling $ 44,269,000 to procure inventory from various vendors. Certain of these purchase orders may be canceled by the Company, subject to cancellation penalties. These purchase commitments relate primarily to expected sales in 2025. | text | 44269000 | monetaryItemType | text: <entity> 44269000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had outstanding purchase orders totaling $ 44,269,000 to procure inventory from various vendors. Certain of these purchase orders may be canceled by the Company, subject to cancellation penalties. These purchase commitments relate primarily to expected sales in 2025. </context> | us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted |
A significant portion of the Company's outstanding inventory purchase orders as of December 31, 2024, as well as additional preauthorized commitments to procure strategic components based on the Company's expected customer demand, are placed with the Company's primary contract manufacturer for the Company's assembled products. The Company purchased $ 17,461,000 , $ 10,616,000 , and $ 5,269,000 in 2024, 2023, and 2022, respectively, of inventories as a result of the Company's obligation to purchase any non-cancelable and non-returnable components that have been purchased by the contract manufacturer with the Company's preauthorization, when these components have not been consumed within the period defined in the terms of the Company's agreement with this contract manufacturer. While the Company typically expects such purchased components to be used in future production of Cognex finished goods, these components are considered in the Company's reserve estimate for excess and obsolete inventory. Furthermore, the Company accrues for losses on commitments for the future purchase of non-cancelable and non-returnable components from this contract manufacturer at the time that circumstances, such as changes in demand, indicate that the value of the components may not be recoverable, the loss is probable, and management has the ability to reasonably estimate the amount of the loss. | text | 17461000 | monetaryItemType | text: <entity> 17461000 </entity> <entity type> monetaryItemType </entity type> <context> A significant portion of the Company's outstanding inventory purchase orders as of December 31, 2024, as well as additional preauthorized commitments to procure strategic components based on the Company's expected customer demand, are placed with the Company's primary contract manufacturer for the Company's assembled products. The Company purchased $ 17,461,000 , $ 10,616,000 , and $ 5,269,000 in 2024, 2023, and 2022, respectively, of inventories as a result of the Company's obligation to purchase any non-cancelable and non-returnable components that have been purchased by the contract manufacturer with the Company's preauthorization, when these components have not been consumed within the period defined in the terms of the Company's agreement with this contract manufacturer. While the Company typically expects such purchased components to be used in future production of Cognex finished goods, these components are considered in the Company's reserve estimate for excess and obsolete inventory. Furthermore, the Company accrues for losses on commitments for the future purchase of non-cancelable and non-returnable components from this contract manufacturer at the time that circumstances, such as changes in demand, indicate that the value of the components may not be recoverable, the loss is probable, and management has the ability to reasonably estimate the amount of the loss. </context> | us-gaap:OtherInventoryPurchasedGoods |
A significant portion of the Company's outstanding inventory purchase orders as of December 31, 2024, as well as additional preauthorized commitments to procure strategic components based on the Company's expected customer demand, are placed with the Company's primary contract manufacturer for the Company's assembled products. The Company purchased $ 17,461,000 , $ 10,616,000 , and $ 5,269,000 in 2024, 2023, and 2022, respectively, of inventories as a result of the Company's obligation to purchase any non-cancelable and non-returnable components that have been purchased by the contract manufacturer with the Company's preauthorization, when these components have not been consumed within the period defined in the terms of the Company's agreement with this contract manufacturer. While the Company typically expects such purchased components to be used in future production of Cognex finished goods, these components are considered in the Company's reserve estimate for excess and obsolete inventory. Furthermore, the Company accrues for losses on commitments for the future purchase of non-cancelable and non-returnable components from this contract manufacturer at the time that circumstances, such as changes in demand, indicate that the value of the components may not be recoverable, the loss is probable, and management has the ability to reasonably estimate the amount of the loss. | text | 10616000 | monetaryItemType | text: <entity> 10616000 </entity> <entity type> monetaryItemType </entity type> <context> A significant portion of the Company's outstanding inventory purchase orders as of December 31, 2024, as well as additional preauthorized commitments to procure strategic components based on the Company's expected customer demand, are placed with the Company's primary contract manufacturer for the Company's assembled products. The Company purchased $ 17,461,000 , $ 10,616,000 , and $ 5,269,000 in 2024, 2023, and 2022, respectively, of inventories as a result of the Company's obligation to purchase any non-cancelable and non-returnable components that have been purchased by the contract manufacturer with the Company's preauthorization, when these components have not been consumed within the period defined in the terms of the Company's agreement with this contract manufacturer. While the Company typically expects such purchased components to be used in future production of Cognex finished goods, these components are considered in the Company's reserve estimate for excess and obsolete inventory. Furthermore, the Company accrues for losses on commitments for the future purchase of non-cancelable and non-returnable components from this contract manufacturer at the time that circumstances, such as changes in demand, indicate that the value of the components may not be recoverable, the loss is probable, and management has the ability to reasonably estimate the amount of the loss. </context> | us-gaap:OtherInventoryPurchasedGoods |
A significant portion of the Company's outstanding inventory purchase orders as of December 31, 2024, as well as additional preauthorized commitments to procure strategic components based on the Company's expected customer demand, are placed with the Company's primary contract manufacturer for the Company's assembled products. The Company purchased $ 17,461,000 , $ 10,616,000 , and $ 5,269,000 in 2024, 2023, and 2022, respectively, of inventories as a result of the Company's obligation to purchase any non-cancelable and non-returnable components that have been purchased by the contract manufacturer with the Company's preauthorization, when these components have not been consumed within the period defined in the terms of the Company's agreement with this contract manufacturer. While the Company typically expects such purchased components to be used in future production of Cognex finished goods, these components are considered in the Company's reserve estimate for excess and obsolete inventory. Furthermore, the Company accrues for losses on commitments for the future purchase of non-cancelable and non-returnable components from this contract manufacturer at the time that circumstances, such as changes in demand, indicate that the value of the components may not be recoverable, the loss is probable, and management has the ability to reasonably estimate the amount of the loss. | text | 5269000 | monetaryItemType | text: <entity> 5269000 </entity> <entity type> monetaryItemType </entity type> <context> A significant portion of the Company's outstanding inventory purchase orders as of December 31, 2024, as well as additional preauthorized commitments to procure strategic components based on the Company's expected customer demand, are placed with the Company's primary contract manufacturer for the Company's assembled products. The Company purchased $ 17,461,000 , $ 10,616,000 , and $ 5,269,000 in 2024, 2023, and 2022, respectively, of inventories as a result of the Company's obligation to purchase any non-cancelable and non-returnable components that have been purchased by the contract manufacturer with the Company's preauthorization, when these components have not been consumed within the period defined in the terms of the Company's agreement with this contract manufacturer. While the Company typically expects such purchased components to be used in future production of Cognex finished goods, these components are considered in the Company's reserve estimate for excess and obsolete inventory. Furthermore, the Company accrues for losses on commitments for the future purchase of non-cancelable and non-returnable components from this contract manufacturer at the time that circumstances, such as changes in demand, indicate that the value of the components may not be recoverable, the loss is probable, and management has the ability to reasonably estimate the amount of the loss. </context> | us-gaap:OtherInventoryPurchasedGoods |
Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 10,705,000 and $ 13,265,000 as of December 31, 2024 and 2023, respectively. The amount of amortization during 2024 related to costs deferred as of December 31, 2023 amounted to $ 12,512,000 | text | 10705000 | monetaryItemType | text: <entity> 10705000 </entity> <entity type> monetaryItemType </entity type> <context> Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 10,705,000 and $ 13,265,000 as of December 31, 2024 and 2023, respectively. The amount of amortization during 2024 related to costs deferred as of December 31, 2023 amounted to $ 12,512,000 </context> | us-gaap:CapitalizedContractCostGross |
Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 10,705,000 and $ 13,265,000 as of December 31, 2024 and 2023, respectively. The amount of amortization during 2024 related to costs deferred as of December 31, 2023 amounted to $ 12,512,000 | text | 13265000 | monetaryItemType | text: <entity> 13265000 </entity> <entity type> monetaryItemType </entity type> <context> Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 10,705,000 and $ 13,265,000 as of December 31, 2024 and 2023, respectively. The amount of amortization during 2024 related to costs deferred as of December 31, 2023 amounted to $ 12,512,000 </context> | us-gaap:CapitalizedContractCostGross |
Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 10,705,000 and $ 13,265,000 as of December 31, 2024 and 2023, respectively. The amount of amortization during 2024 related to costs deferred as of December 31, 2023 amounted to $ 12,512,000 | text | 12512000 | monetaryItemType | text: <entity> 12512000 </entity> <entity type> monetaryItemType </entity type> <context> Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 10,705,000 and $ 13,265,000 as of December 31, 2024 and 2023, respectively. The amount of amortization during 2024 related to costs deferred as of December 31, 2023 amounted to $ 12,512,000 </context> | us-gaap:OtherAmortizationOfDeferredCharges |
The Company has 400,000 shares of authorized but unissued $ .01 par value preferred stock. | text | 400000 | sharesItemType | text: <entity> 400000 </entity> <entity type> sharesItemType </entity type> <context> The Company has 400,000 shares of authorized but unissued $ .01 par value preferred stock. </context> | us-gaap:PreferredStockSharesAuthorized |
The Company has 400,000 shares of authorized but unissued $ .01 par value preferred stock. | text | .01 | perShareItemType | text: <entity> .01 </entity> <entity type> perShareItemType </entity type> <context> The Company has 400,000 shares of authorized but unissued $ .01 par value preferred stock. </context> | us-gaap:PreferredStockParOrStatedValuePerShare |
The Company has 300,000,000 shares of authorized $ .002 par value common stock. | text | 300000000 | sharesItemType | text: <entity> 300000000 </entity> <entity type> sharesItemType </entity type> <context> The Company has 300,000,000 shares of authorized $ .002 par value common stock. </context> | us-gaap:CommonStockSharesAuthorized |
The Company has 300,000,000 shares of authorized $ .002 par value common stock. | text | .002 | perShareItemType | text: <entity> .002 </entity> <entity type> perShareItemType </entity type> <context> The Company has 300,000,000 shares of authorized $ .002 par value common stock. </context> | us-gaap:CommonStockParOrStatedValuePerShare |
In March 2020, the Company's Board of Directors authorized the repurchase of $ 200,000,000 of the Company's common stock. Under this March 2020 program, in addition to repurchases made in prior years, the Company repurchased 1,677,000 shares at a cost of $ 117,000,000 in 2022, which completed purchases under the March 2020 program. | text | 1677000 | sharesItemType | text: <entity> 1677000 </entity> <entity type> sharesItemType </entity type> <context> In March 2020, the Company's Board of Directors authorized the repurchase of $ 200,000,000 of the Company's common stock. Under this March 2020 program, in addition to repurchases made in prior years, the Company repurchased 1,677,000 shares at a cost of $ 117,000,000 in 2022, which completed purchases under the March 2020 program. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
In March 2020, the Company's Board of Directors authorized the repurchase of $ 200,000,000 of the Company's common stock. Under this March 2020 program, in addition to repurchases made in prior years, the Company repurchased 1,677,000 shares at a cost of $ 117,000,000 in 2022, which completed purchases under the March 2020 program. | text | 117000000 | monetaryItemType | text: <entity> 117000000 </entity> <entity type> monetaryItemType </entity type> <context> In March 2020, the Company's Board of Directors authorized the repurchase of $ 200,000,000 of the Company's common stock. Under this March 2020 program, in addition to repurchases made in prior years, the Company repurchased 1,677,000 shares at a cost of $ 117,000,000 in 2022, which completed purchases under the March 2020 program. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. | text | 1682000 | sharesItemType | text: <entity> 1682000 </entity> <entity type> sharesItemType </entity type> <context> In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. </context> | us-gaap:StockRedeemedOrCalledDuringPeriodShares |
In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. | text | 87314000 | monetaryItemType | text: <entity> 87314000 </entity> <entity type> monetaryItemType </entity type> <context> In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. </context> | us-gaap:StockRedeemedOrCalledDuringPeriodValue |
In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. | text | 1723000 | sharesItemType | text: <entity> 1723000 </entity> <entity type> sharesItemType </entity type> <context> In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. </context> | us-gaap:StockRedeemedOrCalledDuringPeriodShares |
In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. | text | 79794000 | monetaryItemType | text: <entity> 79794000 </entity> <entity type> monetaryItemType </entity type> <context> In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. </context> | us-gaap:StockRedeemedOrCalledDuringPeriodValue |
In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. | text | 1711000 | sharesItemType | text: <entity> 1711000 </entity> <entity type> sharesItemType </entity type> <context> In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. </context> | us-gaap:StockRedeemedOrCalledDuringPeriodShares |
In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. | text | 67085000 | monetaryItemType | text: <entity> 67085000 </entity> <entity type> monetaryItemType </entity type> <context> In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. </context> | us-gaap:StockRedeemedOrCalledDuringPeriodValue |
In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. | text | 265807000 | monetaryItemType | text: <entity> 265807000 </entity> <entity type> monetaryItemType </entity type> <context> In March 2022, the Company's Board of Directors authorized the repurchase of an additional $ 500,000,000 of the Company's common stock. Under this March 2022 program, the Company repurchased 1,682,000 shares at a cost of $ 87,314,000 in 2022, 1,723,000 shares at a cost of $ 79,794,000 in 2023, and 1,711,000 shares at a cost of $ 67,085,000 in 2024, leaving a remaining balance of $ 265,807,000 as of December 31, 2024. The 2023 repurchase included $ 446,000 of buyback Excise Tax in accordance with the Inflation Reduction Act of 2022. </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
The Company’s Board of Directors declared and paid cash dividends of $ 0.065 per share in the first, second, and third quarters of 2022, $ 0.070 per share in the fourth quarter of 2022 and in the first, second, and third quarters of 2023, and $ 0.075 per share in the fourth quarter of 2023 and in the first, second, and third quarters of 2024. The dividend was increased to $ 0.080 per share in the fourth quarter of 2024. | text | 0.065 | perShareItemType | text: <entity> 0.065 </entity> <entity type> perShareItemType </entity type> <context> The Company’s Board of Directors declared and paid cash dividends of $ 0.065 per share in the first, second, and third quarters of 2022, $ 0.070 per share in the fourth quarter of 2022 and in the first, second, and third quarters of 2023, and $ 0.075 per share in the fourth quarter of 2023 and in the first, second, and third quarters of 2024. The dividend was increased to $ 0.080 per share in the fourth quarter of 2024. </context> | us-gaap:CommonStockDividendsPerShareCashPaid |
The Company’s Board of Directors declared and paid cash dividends of $ 0.065 per share in the first, second, and third quarters of 2022, $ 0.070 per share in the fourth quarter of 2022 and in the first, second, and third quarters of 2023, and $ 0.075 per share in the fourth quarter of 2023 and in the first, second, and third quarters of 2024. The dividend was increased to $ 0.080 per share in the fourth quarter of 2024. | text | 0.070 | perShareItemType | text: <entity> 0.070 </entity> <entity type> perShareItemType </entity type> <context> The Company’s Board of Directors declared and paid cash dividends of $ 0.065 per share in the first, second, and third quarters of 2022, $ 0.070 per share in the fourth quarter of 2022 and in the first, second, and third quarters of 2023, and $ 0.075 per share in the fourth quarter of 2023 and in the first, second, and third quarters of 2024. The dividend was increased to $ 0.080 per share in the fourth quarter of 2024. </context> | us-gaap:CommonStockDividendsPerShareCashPaid |
The Company’s Board of Directors declared and paid cash dividends of $ 0.065 per share in the first, second, and third quarters of 2022, $ 0.070 per share in the fourth quarter of 2022 and in the first, second, and third quarters of 2023, and $ 0.075 per share in the fourth quarter of 2023 and in the first, second, and third quarters of 2024. The dividend was increased to $ 0.080 per share in the fourth quarter of 2024. | text | 0.075 | perShareItemType | text: <entity> 0.075 </entity> <entity type> perShareItemType </entity type> <context> The Company’s Board of Directors declared and paid cash dividends of $ 0.065 per share in the first, second, and third quarters of 2022, $ 0.070 per share in the fourth quarter of 2022 and in the first, second, and third quarters of 2023, and $ 0.075 per share in the fourth quarter of 2023 and in the first, second, and third quarters of 2024. The dividend was increased to $ 0.080 per share in the fourth quarter of 2024. </context> | us-gaap:CommonStockDividendsPerShareCashPaid |
The Company’s Board of Directors declared and paid cash dividends of $ 0.065 per share in the first, second, and third quarters of 2022, $ 0.070 per share in the fourth quarter of 2022 and in the first, second, and third quarters of 2023, and $ 0.075 per share in the fourth quarter of 2023 and in the first, second, and third quarters of 2024. The dividend was increased to $ 0.080 per share in the fourth quarter of 2024. | text | 0.080 | perShareItemType | text: <entity> 0.080 </entity> <entity type> perShareItemType </entity type> <context> The Company’s Board of Directors declared and paid cash dividends of $ 0.065 per share in the first, second, and third quarters of 2022, $ 0.070 per share in the fourth quarter of 2022 and in the first, second, and third quarters of 2023, and $ 0.075 per share in the fourth quarter of 2023 and in the first, second, and third quarters of 2024. The dividend was increased to $ 0.080 per share in the fourth quarter of 2024. </context> | us-gaap:CommonStockDividendsPerShareCashPaid |
The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). In May 2023, the shareholders of the Company approved the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”). The 2023 Plan permits awards of stock options (both incentive and non-qualified options), stock appreciation rights, RSUs, and PRSUs. Up to 8,100,000 shares of common stock (subject to adjustment in the event of stock splits and other similar events) may be issued pursuant to awards granted under the 2023 Plan. In connection with the approval of the 2023 Plan, no further awards will be made under the Cognex Corporation 2001 General Stock Option Plan, as amended and restated (the “2001 Plan”), and the Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (the “2007 Plan”). With the approval of the 2023 Plan, the 10,610,800 shares of common stock subject to awards granted under the 2001 Plan and the 2007 Plan that were outstanding as of May 3, 2023 may become eligible for issuance under the 2023 Plan if such awards are forfeited, cancelled, or otherwise terminated (other than by exercise) (the “Carryover Shares”). As of December 31, 2024, forfeitures, cancellations, and other terminations from the 2001 Plan and the 2007 Plan have resulted in 1,142,995 Carryover Shares, raising the authorized total shares that may be issued under the 2023 Plan to 9,242,995 . | text | 8100000 | sharesItemType | text: <entity> 8100000 </entity> <entity type> sharesItemType </entity type> <context> The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). In May 2023, the shareholders of the Company approved the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”). The 2023 Plan permits awards of stock options (both incentive and non-qualified options), stock appreciation rights, RSUs, and PRSUs. Up to 8,100,000 shares of common stock (subject to adjustment in the event of stock splits and other similar events) may be issued pursuant to awards granted under the 2023 Plan. In connection with the approval of the 2023 Plan, no further awards will be made under the Cognex Corporation 2001 General Stock Option Plan, as amended and restated (the “2001 Plan”), and the Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (the “2007 Plan”). With the approval of the 2023 Plan, the 10,610,800 shares of common stock subject to awards granted under the 2001 Plan and the 2007 Plan that were outstanding as of May 3, 2023 may become eligible for issuance under the 2023 Plan if such awards are forfeited, cancelled, or otherwise terminated (other than by exercise) (the “Carryover Shares”). As of December 31, 2024, forfeitures, cancellations, and other terminations from the 2001 Plan and the 2007 Plan have resulted in 1,142,995 Carryover Shares, raising the authorized total shares that may be issued under the 2023 Plan to 9,242,995 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). In May 2023, the shareholders of the Company approved the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”). The 2023 Plan permits awards of stock options (both incentive and non-qualified options), stock appreciation rights, RSUs, and PRSUs. Up to 8,100,000 shares of common stock (subject to adjustment in the event of stock splits and other similar events) may be issued pursuant to awards granted under the 2023 Plan. In connection with the approval of the 2023 Plan, no further awards will be made under the Cognex Corporation 2001 General Stock Option Plan, as amended and restated (the “2001 Plan”), and the Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (the “2007 Plan”). With the approval of the 2023 Plan, the 10,610,800 shares of common stock subject to awards granted under the 2001 Plan and the 2007 Plan that were outstanding as of May 3, 2023 may become eligible for issuance under the 2023 Plan if such awards are forfeited, cancelled, or otherwise terminated (other than by exercise) (the “Carryover Shares”). As of December 31, 2024, forfeitures, cancellations, and other terminations from the 2001 Plan and the 2007 Plan have resulted in 1,142,995 Carryover Shares, raising the authorized total shares that may be issued under the 2023 Plan to 9,242,995 . | text | 10610800 | sharesItemType | text: <entity> 10610800 </entity> <entity type> sharesItemType </entity type> <context> The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). In May 2023, the shareholders of the Company approved the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”). The 2023 Plan permits awards of stock options (both incentive and non-qualified options), stock appreciation rights, RSUs, and PRSUs. Up to 8,100,000 shares of common stock (subject to adjustment in the event of stock splits and other similar events) may be issued pursuant to awards granted under the 2023 Plan. In connection with the approval of the 2023 Plan, no further awards will be made under the Cognex Corporation 2001 General Stock Option Plan, as amended and restated (the “2001 Plan”), and the Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (the “2007 Plan”). With the approval of the 2023 Plan, the 10,610,800 shares of common stock subject to awards granted under the 2001 Plan and the 2007 Plan that were outstanding as of May 3, 2023 may become eligible for issuance under the 2023 Plan if such awards are forfeited, cancelled, or otherwise terminated (other than by exercise) (the “Carryover Shares”). As of December 31, 2024, forfeitures, cancellations, and other terminations from the 2001 Plan and the 2007 Plan have resulted in 1,142,995 Carryover Shares, raising the authorized total shares that may be issued under the 2023 Plan to 9,242,995 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). In May 2023, the shareholders of the Company approved the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”). The 2023 Plan permits awards of stock options (both incentive and non-qualified options), stock appreciation rights, RSUs, and PRSUs. Up to 8,100,000 shares of common stock (subject to adjustment in the event of stock splits and other similar events) may be issued pursuant to awards granted under the 2023 Plan. In connection with the approval of the 2023 Plan, no further awards will be made under the Cognex Corporation 2001 General Stock Option Plan, as amended and restated (the “2001 Plan”), and the Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (the “2007 Plan”). With the approval of the 2023 Plan, the 10,610,800 shares of common stock subject to awards granted under the 2001 Plan and the 2007 Plan that were outstanding as of May 3, 2023 may become eligible for issuance under the 2023 Plan if such awards are forfeited, cancelled, or otherwise terminated (other than by exercise) (the “Carryover Shares”). As of December 31, 2024, forfeitures, cancellations, and other terminations from the 2001 Plan and the 2007 Plan have resulted in 1,142,995 Carryover Shares, raising the authorized total shares that may be issued under the 2023 Plan to 9,242,995 . | text | 1142995 | sharesItemType | text: <entity> 1142995 </entity> <entity type> sharesItemType </entity type> <context> The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). In May 2023, the shareholders of the Company approved the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”). The 2023 Plan permits awards of stock options (both incentive and non-qualified options), stock appreciation rights, RSUs, and PRSUs. Up to 8,100,000 shares of common stock (subject to adjustment in the event of stock splits and other similar events) may be issued pursuant to awards granted under the 2023 Plan. In connection with the approval of the 2023 Plan, no further awards will be made under the Cognex Corporation 2001 General Stock Option Plan, as amended and restated (the “2001 Plan”), and the Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (the “2007 Plan”). With the approval of the 2023 Plan, the 10,610,800 shares of common stock subject to awards granted under the 2001 Plan and the 2007 Plan that were outstanding as of May 3, 2023 may become eligible for issuance under the 2023 Plan if such awards are forfeited, cancelled, or otherwise terminated (other than by exercise) (the “Carryover Shares”). As of December 31, 2024, forfeitures, cancellations, and other terminations from the 2001 Plan and the 2007 Plan have resulted in 1,142,995 Carryover Shares, raising the authorized total shares that may be issued under the 2023 Plan to 9,242,995 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized |
The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). In May 2023, the shareholders of the Company approved the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”). The 2023 Plan permits awards of stock options (both incentive and non-qualified options), stock appreciation rights, RSUs, and PRSUs. Up to 8,100,000 shares of common stock (subject to adjustment in the event of stock splits and other similar events) may be issued pursuant to awards granted under the 2023 Plan. In connection with the approval of the 2023 Plan, no further awards will be made under the Cognex Corporation 2001 General Stock Option Plan, as amended and restated (the “2001 Plan”), and the Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (the “2007 Plan”). With the approval of the 2023 Plan, the 10,610,800 shares of common stock subject to awards granted under the 2001 Plan and the 2007 Plan that were outstanding as of May 3, 2023 may become eligible for issuance under the 2023 Plan if such awards are forfeited, cancelled, or otherwise terminated (other than by exercise) (the “Carryover Shares”). As of December 31, 2024, forfeitures, cancellations, and other terminations from the 2001 Plan and the 2007 Plan have resulted in 1,142,995 Carryover Shares, raising the authorized total shares that may be issued under the 2023 Plan to 9,242,995 . | text | 9242995 | sharesItemType | text: <entity> 9242995 </entity> <entity type> sharesItemType </entity type> <context> The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). In May 2023, the shareholders of the Company approved the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”). The 2023 Plan permits awards of stock options (both incentive and non-qualified options), stock appreciation rights, RSUs, and PRSUs. Up to 8,100,000 shares of common stock (subject to adjustment in the event of stock splits and other similar events) may be issued pursuant to awards granted under the 2023 Plan. In connection with the approval of the 2023 Plan, no further awards will be made under the Cognex Corporation 2001 General Stock Option Plan, as amended and restated (the “2001 Plan”), and the Cognex Corporation 2007 Stock Option and Incentive Plan, as amended and restated (the “2007 Plan”). With the approval of the 2023 Plan, the 10,610,800 shares of common stock subject to awards granted under the 2001 Plan and the 2007 Plan that were outstanding as of May 3, 2023 may become eligible for issuance under the 2023 Plan if such awards are forfeited, cancelled, or otherwise terminated (other than by exercise) (the “Carryover Shares”). As of December 31, 2024, forfeitures, cancellations, and other terminations from the 2001 Plan and the 2007 Plan have resulted in 1,142,995 Carryover Shares, raising the authorized total shares that may be issued under the 2023 Plan to 9,242,995 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
As of December 31, 2024, the Company had 6,458,000 shares available for issuance under its stock plans. Stock options are granted with an exercise price equal to the market value of the Company’s common stock at the grant date and generally vest over four or five years based on continuous employment and expire ten years from the grant date. RSUs generally vest upon three or four years of continuous employment or incrementally over such three or four year periods. PRSUs generally vest upon three years of continuous employment and achievement of performance criteria established by the Compensation Committee of our Board of Directors on or prior to the grant date. Participants are not entitled to dividends on stock options, RSUs, or PRSUs. | text | 6458000 | sharesItemType | text: <entity> 6458000 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, the Company had 6,458,000 shares available for issuance under its stock plans. Stock options are granted with an exercise price equal to the market value of the Company’s common stock at the grant date and generally vest over four or five years based on continuous employment and expire ten years from the grant date. RSUs generally vest upon three or four years of continuous employment or incrementally over such three or four year periods. PRSUs generally vest upon three years of continuous employment and achievement of performance criteria established by the Compensation Committee of our Board of Directors on or prior to the grant date. Participants are not entitled to dividends on stock options, RSUs, or PRSUs. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. | text | 6011000 | monetaryItemType | text: <entity> 6011000 </entity> <entity type> monetaryItemType </entity type> <context> The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. | text | 11104000 | monetaryItemType | text: <entity> 11104000 </entity> <entity type> monetaryItemType </entity type> <context> The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. | text | 12267000 | monetaryItemType | text: <entity> 12267000 </entity> <entity type> monetaryItemType </entity type> <context> The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. | text | 4021000 | monetaryItemType | text: <entity> 4021000 </entity> <entity type> monetaryItemType </entity type> <context> The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. | text | 4691000 | monetaryItemType | text: <entity> 4691000 </entity> <entity type> monetaryItemType </entity type> <context> The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. | text | 2548000 | monetaryItemType | text: <entity> 2548000 </entity> <entity type> monetaryItemType </entity type> <context> The total cash received as a result of stock option exercises was $ 6,011,000 in 2024, $ 11,104,000 in 2023, and $ 12,267,000 in 2022. In connection with these exercises, the tax benefit (expense) realized by the Company was $( 4,021,000 ) in 2024, $( 4,691,000 ) in 2023, and $ 2,548,000 in 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
The weighted-average grant-date fair value of stock options granted was $ 14.89 in 2024, $ 17.76 in 2023, and $ 21.39 in 2022. | text | 14.89 | perShareItemType | text: <entity> 14.89 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted was $ 14.89 in 2024, $ 17.76 in 2023, and $ 21.39 in 2022. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of stock options granted was $ 14.89 in 2024, $ 17.76 in 2023, and $ 21.39 in 2022. | text | 17.76 | perShareItemType | text: <entity> 17.76 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted was $ 14.89 in 2024, $ 17.76 in 2023, and $ 21.39 in 2022. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of stock options granted was $ 14.89 in 2024, $ 17.76 in 2023, and $ 21.39 in 2022. | text | 21.39 | perShareItemType | text: <entity> 21.39 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted was $ 14.89 in 2024, $ 17.76 in 2023, and $ 21.39 in 2022. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. | text | 38.90 | perShareItemType | text: <entity> 38.90 </entity> <entity type> perShareItemType </entity type> <context> The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. | text | 46.14 | perShareItemType | text: <entity> 46.14 </entity> <entity type> perShareItemType </entity type> <context> The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. | text | 58.06 | perShareItemType | text: <entity> 58.06 </entity> <entity type> perShareItemType </entity type> <context> The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. | text | 429000 | sharesItemType | text: <entity> 429000 </entity> <entity type> sharesItemType </entity type> <context> The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. | text | 521000 | sharesItemType | text: <entity> 521000 </entity> <entity type> sharesItemType </entity type> <context> The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. | text | 192000 | sharesItemType | text: <entity> 192000 </entity> <entity type> sharesItemType </entity type> <context> The fair value of RSUs was determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair value of RSUs granted was $ 38.90 in 2024, $ 46.14 in 2023, and $ 58.06 in 2022. There were 429,000 , 521,000 , and 192,000 RSUs that vested in 2024, 2023, and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. | text | 5017000 | monetaryItemType | text: <entity> 5017000 </entity> <entity type> monetaryItemType </entity type> <context> Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. </context> | us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation |
Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. | text | 7836000 | monetaryItemType | text: <entity> 7836000 </entity> <entity type> monetaryItemType </entity type> <context> Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. </context> | us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation |
Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. | text | 2406000 | monetaryItemType | text: <entity> 2406000 </entity> <entity type> monetaryItemType </entity type> <context> Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. </context> | us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation |
Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. | text | 7401000 | monetaryItemType | text: <entity> 7401000 </entity> <entity type> monetaryItemType </entity type> <context> Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. | text | 3229000 | monetaryItemType | text: <entity> 3229000 </entity> <entity type> monetaryItemType </entity type> <context> Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. | text | 1049000 | monetaryItemType | text: <entity> 1049000 </entity> <entity type> monetaryItemType </entity type> <context> Tax obligations for vested RSUs are settled by withholding a portion of the shares prior to distribution to the shareholder. The total cash used by the Company to fund the tax payments was $ 5,017,000 in 2024, $ 7,836,000 in 2023, and $ 2,406,000 in 2022. In connection with these vested RSUs, the tax benefit (expense) realized by the Company was $( 7,401,000 ) in 2024, $( 3,229,000 ) in 2023, and $( 1,049,000 ) in 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The fair value of PRSUs was calculated using a Monte Carlo simulation model to estimate the probability of satisfying the service and market conditions stipulated in the award grant. The weighted average grant-date fair value of PRSUs granted was $ 39.05 in 2024, $ 44.86 in 2023, and $ 62.49 in 2022. No PRSUs vested in 2024, 2023, and 2022. | text | 39.05 | perShareItemType | text: <entity> 39.05 </entity> <entity type> perShareItemType </entity type> <context> The fair value of PRSUs was calculated using a Monte Carlo simulation model to estimate the probability of satisfying the service and market conditions stipulated in the award grant. The weighted average grant-date fair value of PRSUs granted was $ 39.05 in 2024, $ 44.86 in 2023, and $ 62.49 in 2022. No PRSUs vested in 2024, 2023, and 2022. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The fair value of PRSUs was calculated using a Monte Carlo simulation model to estimate the probability of satisfying the service and market conditions stipulated in the award grant. The weighted average grant-date fair value of PRSUs granted was $ 39.05 in 2024, $ 44.86 in 2023, and $ 62.49 in 2022. No PRSUs vested in 2024, 2023, and 2022. | text | 44.86 | perShareItemType | text: <entity> 44.86 </entity> <entity type> perShareItemType </entity type> <context> The fair value of PRSUs was calculated using a Monte Carlo simulation model to estimate the probability of satisfying the service and market conditions stipulated in the award grant. The weighted average grant-date fair value of PRSUs granted was $ 39.05 in 2024, $ 44.86 in 2023, and $ 62.49 in 2022. No PRSUs vested in 2024, 2023, and 2022. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The fair value of PRSUs was calculated using a Monte Carlo simulation model to estimate the probability of satisfying the service and market conditions stipulated in the award grant. The weighted average grant-date fair value of PRSUs granted was $ 39.05 in 2024, $ 44.86 in 2023, and $ 62.49 in 2022. No PRSUs vested in 2024, 2023, and 2022. | text | 62.49 | perShareItemType | text: <entity> 62.49 </entity> <entity type> perShareItemType </entity type> <context> The fair value of PRSUs was calculated using a Monte Carlo simulation model to estimate the probability of satisfying the service and market conditions stipulated in the award grant. The weighted average grant-date fair value of PRSUs granted was $ 39.05 in 2024, $ 44.86 in 2023, and $ 62.49 in 2022. No PRSUs vested in 2024, 2023, and 2022. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2024, total unrecognized compensation expense, net of estimated forfeitures, related to non-vested stock-based awards, including stock options, RSUs, and PRSUs, was $ 51,147,000 , which is expected to be recognized over a weighted-average period of 1.5 years. | text | 51147000 | monetaryItemType | text: <entity> 51147000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, total unrecognized compensation expense, net of estimated forfeitures, related to non-vested stock-based awards, including stock options, RSUs, and PRSUs, was $ 51,147,000 , which is expected to be recognized over a weighted-average period of 1.5 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions |
The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. | text | 52443000 | monetaryItemType | text: <entity> 52443000 </entity> <entity type> monetaryItemType </entity type> <context> The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. | text | 8387000 | monetaryItemType | text: <entity> 8387000 </entity> <entity type> monetaryItemType </entity type> <context> The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. | text | 54768000 | monetaryItemType | text: <entity> 54768000 </entity> <entity type> monetaryItemType </entity type> <context> The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. | text | 8442000 | monetaryItemType | text: <entity> 8442000 </entity> <entity type> monetaryItemType </entity type> <context> The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. | text | 54505000 | monetaryItemType | text: <entity> 54505000 </entity> <entity type> monetaryItemType </entity type> <context> The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. | text | 9540000 | monetaryItemType | text: <entity> 9540000 </entity> <entity type> monetaryItemType </entity type> <context> The total stock-based compensation expense and the related income tax benefit recognized was $ 52,443,000 and $ 8,387,000 , respectively, in 2024, $ 54,768,000 and $ 8,442,000 , respectively, in 2023, and $ 54,505,000 and $ 9,540,000 , respectively, in 2022. No compensation expense was capitalized in 2024, 2023, or 2022. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. </context> | us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent |
Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. </context> | us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch |
Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. | text | 6 | percentItemType | text: <entity> 6 </entity> <entity type> percentItemType </entity type> <context> Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. </context> | us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent |
Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. | text | 3535000 | monetaryItemType | text: <entity> 3535000 </entity> <entity type> monetaryItemType </entity type> <context> Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. </context> | us-gaap:DefinedContributionPlanCostRecognized |
Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. | text | 3392000 | monetaryItemType | text: <entity> 3392000 </entity> <entity type> monetaryItemType </entity type> <context> Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. </context> | us-gaap:DefinedContributionPlanCostRecognized |
Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. | text | 3284000 | monetaryItemType | text: <entity> 3284000 </entity> <entity type> monetaryItemType </entity type> <context> Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. </context> | us-gaap:DefinedContributionPlanCostRecognized |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 35253000 | monetaryItemType | text: <entity> 35253000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 16039000 | monetaryItemType | text: <entity> 16039000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 48546000 | monetaryItemType | text: <entity> 48546000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 96236000 | monetaryItemType | text: <entity> 96236000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 119309000 | monetaryItemType | text: <entity> 119309000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 202149000 | monetaryItemType | text: <entity> 202149000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.